United Kingdom
Global Site
Latin America
Brazil
South Africa
United Arab Emirates
Austria
French Canadian
United States
Italia
Nederlands
Deutschland
Canada
France
Czech RepublicLet’s Heal™ is the result of 75 years experience in developing our products to help you test, protect, promote and comfort the wound towards healing.
WOUNDCHEK™ Protease Status
For more information on the potential clinical value of a protease test, click one of the links below:
Defining EPA (elevated protease activity) and why a test able to detect EPA is needed and clinically relevant:
- UK round table meeting – Protease Diagnostic in wound care
- Protease Activity Levels Associated with Healing Status of Chronic Wounds
- The Importance of Proteases in Wound Healing and Wound Assessment
- The role of Proteases in Wound Diagnostics consensus
- Targeted Use of Collagen/ORC Improves Clinical Outcome
- You Can’t Manage What You Can’t Measure: Welcome to 21st Century Wound Care
Diagnostics in wound care:
Understanding proteases and healing in wound care:
- What's the Delay? The Role of Inflammatory Proteases in Wound Healing
- MMPs Made Easy
- Do you know your Proteases?
- Webcasts of Cape Town Symposium
- Systagenix sponsors virtual conference with Wounds International
- Visit the proteasemarker website
Please refer in full to the Instructions for use leaflet provided in the product packaging, specific to your region.
Systagenix is not responsible for the content of external websites.
Disclaimer
The product information on this page is not intended for, or to be used by health care professionals or users in the United States
WOUNDCHEK™ Protease Status references
1. Serena T. et al. Protease activity levels associated with healing status of chronic wounds.Poster, Wounds UK 2011.
2. Snyder RJ, Cullen B, Nisbet LT. An audit to assess the perspectives of US wound care specialists regarding the importance of proteases in wound healing and wound assessment. International Wound Journal 2012; 29 July online publication.
3. International consensus. The role of proteases in wound diagnostics. An expert working group review. London: Wounds International, 2011.
4. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The healthcare costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26(6):1790–1795.
5. Shearer A, Scuffham P, Gordois A, Oglesby A. Predicted costs and outcomes from reduced vibration detection in people with diabetes in the U.S. Diabetes Care. 2003;26(8):2305–2310.
6. Instructions for Use 2011.
7. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994;130(4):489-493.
8. Consensus on Use of a Diagnostic Tool in Stalled Wounds to Identify Excess Protease Levels. The Protease Diagnostic Consensus Panel. Ostomy Wound Management. Ostomy Wound Management 2011;57(12): 36-48.